Challenges in the Management of the Patients with COVID-19 Infected Cushing’s Syndrome: Two Cases And Literature Review

We will discuss the course of COVID-19 infection over a 32-year-old and 76-year-old female patient with Cushing syndrome who applied to our clinic as a tertiary referral centre.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Coronavirus disease-2019 (COVID-19) has become a serious health problem in Turkey and the world.

📊

Key Findings & Data:The diagnosis stage of many chronic diseases, the treatment process and the status of being affected by COVID-19 have become the focus of attention in the medical community during the pandemic, which has been continuing for nine months.

💡

Conclusion & Impact:We will discuss the course of COVID-19 infection over a 32-year-old and 76-year-old female patient with Cushing syndrome who applied to our clinic as a tertiary referral centre.

🔬Design:Research Article

📍Scope:2019 Verileri

⚙️Variables:Cushing’s syndrome · ectopic Cushing’s disease · COVID-19

Abstract

Coronavirus disease-2019 (COVID-19) has become a serious health problem in Turkey and the world. The diagnosis stage of many chronic diseases, the treatment process and the status of being affected by COVID-19 have become the focus of attention in the medical community during the pandemic, which has been continuing for nine months. We will discuss the course of COVID-19 infection over a 32-year-old and 76-year-old female patient with Cushing syndrome who applied to our clinic as a tertiary referral centre.

Keywords

Cushing’s syndrome ectopic Cushing’s disease COVID-19 hypercortisolism management

🔖

Cite This Article

BABAYEVA, A., COŞKUN, M., YALÇIN, M. M., ÜNLÜ, S., ÖZGER, H. S., BATMAZ, L., ALTINOVA, A. E., AKTURK, M., TÖRÜNER, F. B., YETKİN, İ. (2022). Challenges in the Management of the Patients with COVID-19 Infected Cushing’s Syndrome: Two Cases And Literature Review. Turkish Journal of Internal Medicine, Cilt: 4 - Sayı: 3, 139–147. https://ajindex.com/articles/808964

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (5)

COVID Live Update: 195,172,426 Cases and 4,180,122 Deaths from the Coronavirus - Worldometer. Avaliable at: https://www.worldometers.info/coronavirus/?zarsrc=130. Accessed July 26, 2021.
Somasundaram NP, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, Yogendranathan N, Gamage KKK, de Silva NL, Sumanatilleke M, Katulanda P, Grossman AB. The impact of SARS-Cov-2 virus infection on the Endocrine system. J Endocr Soc. 2020 Jul 2;4(8):bvaa082. doi: 10.1210/jendso/bvaa082. Aranda G, Lopez C, Fernandez-Ruiz R, Esteban Y, Garcia-Eguren G, Mora M, Halperin I, Casals G, Enseñat J, Hanzu FA. Circulatory immune cells in Cushing syndrome: Bystanders or active contributors to atherometabolic injury? A study of adhesion and activation of cell surface markers. Int J Endocrinol. 2017;2017:2912763. doi: 10.1155/2017/2912763. Hasenmajer V, Sbardella E, Sciarra F, Minnetti M, Isidori AM, Venneri MA. The immune system in Cushing’s syndrome. Trends Endocrinol Metab. 2020 Sep;31(9):655-69. doi: 10.1016/j.tem.2020.04.004. Kakodkar P, Kaka N, Baig MN. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus. 2020 Apr 6;12(4):e7560. doi: 10.7759/cureus.7560. Pivonello R, Ferrigno R, Isidori AM, Biller BMK, Grossman AB, Colao A. COVID-19 and Cushing’s syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol. 2020 Aug;8(8):654-6. doi: 10.1016/S2213-8587(20)30215-1. T.C. Saglık Bakanlıgı. COVID-19 Bilgilendirme Platformu. COVID-19 rehberi. Avaliable at: https://covid19.saglik.gov.tr/TR-66301/covid-19-rehberi.html. Accessed August 29, 2021.
Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19. J Infect. 2020 Jun;80(6):607-13. doi: 10.1016/j.jinf.2020.03.037. Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020 May;79(5):667-8. doi: 10.1136/annrheumdis-2020-217424.
Fleseriu M, Buchfelder M, Cetas JS, Fazeli PK, Mallea-Gil SM, Gurnell M, McCormack A, Pineyro MM, Syro LV, Tritos NA, Marcus HJ. Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective. Pituitary. 2020 Aug;23(4):327-37. doi: 10.1007/s11102-020-01059-7.
Newell-Price J, Nieman LK, Reincke M,